Cancer, Cancer 2021, Ovarian Cancer, Patient stories - Norton Healthcare, Uterine Cancer

Living with ovarian cancer, Stephanie Virgin is a focused mom and advocate for awareness

Photo by Anna May Photography Stephanie Virgin was 29 and hoping to start a family, so ovarian cancer was the last thing on her mind — even when she experienced textbook symptoms. The Louisville native chalked up her back pain to the high heels she wore to her work in real estate. She thought the…

Read Full Story
Cancer, Cancer 2021, Lymphoma, News, Patient stories - Norton Healthcare

In sickness and in health

The lump on Lonnie Gardner’s left arm looked innocuous. Maybe an insect bite, he reasoned. For weeks in 2014, the human resources professional went about his business, unconcerned. But the lump got larger and caught the attention of his wife, Megan, who suggested he consult with a dermatologist. More weeks went by. She kept insisting….

Read Full Story
Cancer, Cancer 2021, News, Patient stories - Norton Healthcare

Wanda’s tale of triumph

I have gone through it — you know, the losing of my hair, losing my fingernails, my toenails, my breasts. I was diagnosed with stage 4 breast cancer on July 28, 2008. That date is when everything changed. It kept playing in my head: I have cancer, I have cancer, I have cancer. My concern…

Read Full Story
Cancer 2021, COVID19, Research and Clinical Trials

Norton Healthcare physicians first in world to test cancer drug as COVID-19 treatment

A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor. This oral drug, manufactured by Karyopharm Therapeutics Inc. and marketed as XPOVIO, is currently approved at higher doses by the U.S. Food and Drug Administration (FDA) as a treatment for cancer patients…

Read Full Story
Cancer, Cancer 2021, Lung Cancer, Patient stories - Norton Healthcare

Lung cancer survivor credits ‘lucky’ outcome to early detection and expertise

David Elder considers himself lucky. Had things gone differently, the 66-year-old retired accounting professional might have become another lung cancer death statistic. In 2017, David developed what he thought was a minor hernia. He had bouts of stomach pain and over a two-month period lost about 40 pounds. David was familiar with lung cancer’s symptoms…

Read Full Story
Brain Cancer, Brain Tumor, Brain Tumor, Cancer, Cancer 2021, Neurosciences

Glioblastoma clinical trial uses immunotherapy in fight against the deadliest brain cancer

Louisville researchers are turning their success with immunotherapy toward a new foe — the deadly glioblastoma brain cancer. Renato V. LaRocca, M.D., a neuro-oncologist and cancer medicine specialist with Norton Cancer Institute, is working on new treatments that use immunotherapy to turn the body’s immune system against the cancer. Norton Healthcare is among several institutions…

Read Full Story
Cancer, Cancer 2021, Employee stories - Norton Healthcare

Proud Kentuckian providing lung cancer treatment to fight state’s worst cancer challenge

Adam D. Lye, M.D., is a proud Kentuckian. The medical oncologist/hematologist grew up in Covington and attended medical school at the University of Kentucky College of Medicine in Lexington. For fun, Dr. Lye and his family like to go for hikes around the commonwealth. He also follows Kentucky country musicians Chris Stapleton, Sturgill Simpson and…

Read Full Story
Cancer, Cancer 2021, Employee stories - Norton Healthcare, News

Cancer specialist looks to help solve Amelia Earhart mystery

As a cancer specialist and neuro-oncologist at Norton Cancer Institute, Renato V. LaRocca, M.D., diagnoses and treats high-grade brain tumors and other solid tumors. Last summer, he applied the same evidence-based approaches he uses to help patients to try and answer one of history’s most vexing questions: What really happened to legendary aviator Amelia Earhart?…

Read Full Story
Cancer, Cancer 2021, Employee stories - Norton Healthcare, Lymphoma, Research and Clinical Trials

Norton cancer specialist’s research paves way for new FDA-approved lymphoma treatment

The U.S. Food and Drug Administration recently approved a new cancer drug that has been available only to patients enrolled by a Norton Cancer Institute physician and one other researcher nationwide. Don A. Stevens, M.D., medical oncologist/hematologist and director of the Hematologic Malignancy Program at Norton Cancer Institute, was one of only two physicians in…

Read Full Story

Schedule an Appointment

Select an appointment date and time from available spots listed below.